Transplantation, AutologousCyclophosphamideHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCystadenomaDoxorubicinInduction ChemotherapyCombined Modality TherapyPeripheral Blood Stem Cell TransplantationMelphalanMultiple MyelomaTransplantation ConditioningTransplantation, HomologousRemission InductionTreatment OutcomeDisease-Free SurvivalEtoposideSalvage TherapyCytarabineBreast NeoplasmsSurvival RateVincristineStem CellsLymphoma, Non-HodgkinHodgkin DiseaseSurvival AnalysisRecurrenceThiotepaBone Marrow TransplantationCarmustineMyeloablative AgonistsHematopoietic Stem Cell MobilizationGraft vs Host DiseaseCisplatinPrognosisBone Marrow PurgingAntineoplastic AgentsAntineoplastic Agents, AlkylatingChemotherapy, AdjuvantHematologic NeoplasmsWhole-Body IrradiationRetrospective StudiesIfosfamideBusulfanDexamethasoneFollow-Up StudiesLymphoma, Mantle-CellAmyloidosisAntibodies, Monoclonal, Murine-DerivedHematopoietic Stem CellsPrednisoneGranulocyte Colony-Stimulating FactorBoronic AcidsLeukemia, Myeloid, AcuteTime FactorsPyrazinesGraft SurvivalLymphoma, FollicularAntigens, CD34CarboplatinDrug Administration ScheduleLymphoma, T-Cell, PeripheralThalidomideLymphomaAutograftsNeoplasm, ResidualLiver TransplantationLeukapheresisIdarubicinNeoplasm StagingMitoxantroneLymphoma, Large B-Cell, DiffusePodophyllotoxinMesenchymal Stem Cell TransplantationMaintenance ChemotherapyNeoplasm Recurrence, LocalProspective StudiesTransplantation ChimeraMyelodysplastic SyndromesLeukemia, MyeloidImmunosuppressive AgentsNeutropeniaMethotrexateTissue DonorsCord Blood Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, B-CellFeasibility StudiesCell TransplantationAntibodies, MonoclonalNeoplasms, Second PrimaryBleomycinDose-Response Relationship, DrugBone MarrowKidney TransplantationNeoadjuvant TherapyEmbryonic Stem CellsEnteropathy-Associated T-Cell LymphomaLeukemia, Plasma Cell